Doris Höglinger

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 7

Top Venues

Journal of cell science

Angewandte Chemie (International ed. in English)

Wellcome open research

Proceedings of the National Academy of Sciences of the United States of America

Ruprecht Karls Universität Heidelberg

European Molecular Biology Laboratory (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ruprecht Karls Universität Heidelberg Apr 01 2017

Germany

Junior group leader :: Biochemistry Center (BZH)

University of Oxford Feb 01 2016 - Mar 31 2017

United Kingdom

Postdoctoral Scientist :: Pharmacology

Education History

European Molecular Biology Laboratory Oct 17 2011 - Nov 30 2015

Germany

PHD :: Cell Biology and Biophysics

Publications

Denisa Jamecna, Doris Höglinger
The use of click chemistry in sphingolipid research. Journal of cell science 137 (6) (2024)
Denisa Jamecna, Doris Höglinger
The use of click chemistry in sphingolipid research. Journal of cell science 137 (6) (2024)
Denisa Jamecna, Doris Höglinger
The use of click chemistry in sphingolipid research. Journal of cell science 137 (6) (2024)
Pia Hartwig, Doris Höglinger
The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation. International journal of molecular sciences 22 (13) (2021)
Nicolai Wagner, Milena Stephan, Doris Höglinger, André Nadler
A Click Cage: Organelle-Specific Uncaging of Lipid Messengers. Angewandte Chemie (International ed. in English) 57 (40) (2018)
Doris Höglinger, André Nadler, Per Haberkant, Joanna Kirkpatrick, Martina Schifferer, Frank Stein, Sebastian Hauke, Forbes D Porter, Carsten Schultz
Trifunctional lipid probes for comprehensive studies of single lipid species in living cells. Proceedings of the National Academy of Sciences of the United States of America 114 (7) (2017)
Paul Fineran, Emyr Lloyd-Evans, Nathan A Lack, Nick Platt, Lianne C Davis, Anthony J Morgan, Doris Höglinger, Raju Venkata V Tatituri, Simon Clark, Ian M Williams, Patricia Tynan, Nada Al Eisa, Evgeniya Nazarova, Ann Williams, Antony Galione, Daniel S Ory, Gurdyal S Besra, David G Russell, Michael B Brenner, Edith Sim, Frances Mary Platt
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway. Wellcome open research 1 (2016)

Doris Höglinger.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Doris Höglinger